key: cord-0682206-6xqyerpt
authors: Onyeghala, Chizaram; Alasia, Datonye; Eyaru, Orezioghene; Nsirim, Paul; Maduka, Omosivie; Osemwengie, Nosa; Ugwueze, Nkem; Ordu, Collins; Igbosi, Ebitei; Irabor, Mary; Eyidia, Emeka
title: Multisystem Inflammatory Syndrome (MIS-C) in an Adolescent Nigerian Girl with COVID-19: A call for vigilance in Africa
date: 2021-02-12
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.02.017
sha: 03e5e7502646860f1748a4fb209b91bb5f76e27c
doc_id: 682206
cord_uid: 6xqyerpt

Most reports of Multisystem Inflammatory Syndrome (MIS-C) have come from Europe and North America. The paucity of reports in Africa is in contrast with the demographics of the series in New York, Paris and UK with children of African ancestry accounting for over 40%, of all cases of MIS-C. With the global trend of higher prevalence of MIS-C in children of African ancestry, enhanced surveillance and awareness for this syndrome in children with COVID-19 in Africa are therefore important. A case report of a 12-year old Nigerian girl with MIS-C is presented in line with the WHO global surveillance especially in areas were MIS-C is considered a rarity. This case report stimulates a call for vigilance and expanded effort at surveillance to promote early recognition and diagnosis of MIS-C in Nigeria and Africa. The favourable outcome and experience from this case will create awareness, expand knowledge, and support clinicians in Nigeria and the African continent in their approach to other potential cases.

At the onset of the COVID-19 pandemic, it was observed that infection was less prevalent in children with a 2% prevalence for people aged ≤ 19 years among a Chinese cohort of 72314 cases. ( Table 1 ). On admission, clinical signs comprised bodyweight of 50Kg (within 75 percentile, (+0.66 SD) for age.), a temperature of 39 o C, respiratory rate of 48 per minute, pulse rate of 135 per minute and blood pressure of 90/50mmHg. Oxygen saturation (SP02) was 76% in room air. The paediatric early warning systems (PEWS) score which was used in monitoring severity and clinical progression was 11 indicative of high risk (NICE, 2017), as displayed in Figure 1 and Table 2 . She had received empirical treatment for bacterial pneumonia with a poor response before referral. Table 3 .

The treatment regimen comprised of initial high flow oxygen at 10 litres per minute via a nonrebreather mask, blood transfusion with intravenous (IV) furosemide to prevent fluid overload, IV ceftriaxone 1g daily for superimposed bacterial infection, IV hydrocortisone 200mg daily, prophylaxis anticoagulation with subcutaneous (SC) enoxaparin 40mg daily, tablets Azithromycin 500mg daily, tablet Paracetamol 1gram three times a day, tablet Hydroxychloroquine 200mg twice a day for 24hrs then 100mg twice a day for 4 days, vitamin A capsules 200,000iu on days 1,2, and 4 and vitamin C tablets at 500mg once a day. On day 5 J o u r n a l P r e -p r o o f of hospitalization, her clinical symptoms improved remarkably with normal vital signs, PEWs score of 0 and 0 respectively, prompting ICU discharge on day 6. The patient was discharged after 14 days of hospitalization following a negative SARS COV-2 test result. She was seen two weeks post-discharge at the clinic with no symptoms, with a long term follow up plan and echocardiography request for cardiac evaluation.

To the best of our knowledge, this is the first reported case of MIS-C in Nigeria and probably 

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Figure 1 : Showing laboratory parameters of the patient 

Multisystem inflammatory syndrome in children: A systematic review

The diagnosis of Kawasaki disease among Nigerian children: a nightmare for the caregivers and the doctors

Multisystem inflammatory syndrome of children

Multisystem Inflammatory Syndrome in Children in New York State

COVID-19-Associated Multisystem Inflammatory Syndrome in Children -United States

COVID-19 and multisystem inflammatory syndrome in children and adolescents

Kawasaki disease in the COVID-19 era: a distinct clinical phenotype? The Lancet

NICE. Paediatric Early Warning Scoring Tool (PEWS): Available from

National Interim Guidelines for Clinical Management of COVID-19 Version 3

The impact of ethnicity on clinical outcomes in COVID-19: A systematic review

Hyperinflammatory shock in children during COVID-19 pandemic

Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian paediatric intensive care units

Multisystem Inflammatory Syndrome in Children in Association with COVID-19

Son MBF. Paediatric inflammatory syndrome temporally related to covid-19

Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

Multisystem inflammatory syndrome in children in South Africa

Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with sars-cov-2

Multisystem inflammatory of children and adolescents with covid-19

Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention